[P1–395]: AMYPAD: A EUROPEAN PUBLIC‐PRIVATE PARTNERSHIP TO INVESTIGATE THE VALUE OF β‐AMYLOID BRAIN SCANS AS A DIAGNOSTIC AND THERAPEUTIC MARKER FOR ALZHEIMER's DISEASE. (1st July 2017) - Farrar, Gill